Literature DB >> 30747121

Developments in human rabies prophylaxis.

M J Warrell.   

Abstract

Rabies is entirely preventable. All deaths are the result of failed prophylaxis. Rabies encephalomyelitis has never been reported in anyone who received both pre-exposure vaccination and a post-exposure booster. Awareness of the risk of contact with rabid animals is crucial. A lack of basic knowledge and the inaccessibility of expensive rabies vaccines can discourage patients bitten by suspected rabid animals from seeking prompt post-exposure prophylaxis. Similarly, people working with mammals, residents of areas where dog rabies is endemic, travellers, and others at risk often fail to take advantage of pre-exposure prophylaxis. However, since human infection by a dog rabies virus has always proved fatal in unvaccinated patients, there is understandable reluctance to accept any change in vaccine protocols. The intramuscular route of delivery is wasteful and the current, low-dose intradermal (ID) regimen is not always economical or universally trusted. A new, one-week ID regimen, using less vaccine, injected at multiple sites, and involving two clinic visits, could increase the accessibility of highly immunogenic prophylaxis and reduce the prohibitive cost. The recent 2018 World Health Organization recommendations for rabies prophylaxis are included.

Entities:  

Keywords:  Dog bite; Economical; Intradermal; Multiple-site; Post-exposure; Pre-exposure; Rabies; Rabies immunoglobulin; Rabies prophylaxis; Rabies vaccine

Mesh:

Substances:

Year:  2018        PMID: 30747121     DOI: 10.20506/rst.37.2.2829

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  3 in total

1.  Updates on Rabies virus disease: is evolution toward "Zombie virus" a tangible threat?

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Acta Biomed       Date:  2021-02-04

2.  Staphylococcus aureus derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations.

Authors:  Rania Ibrahim Shebl; Mohamed E Amer; Tamer M M Abuamara; Emadeldin R Matar; Hassan Fathy Ahmed; Tamer Albasyoni Gomah; Laila E El Moselhy; Mohammed Abu-Elghait; Aly Fahmy Mohamed
Journal:  Clin Exp Vaccine Res       Date:  2021-09-30

3.  A shorter post-exposure prophylaxis regimen for rabies, Pakistan.

Authors:  Naseem Salahuddin; Nadia Ansari; Muhammad Aftab Gohar
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.